Logo

BioFire

In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More

News items for the week of Jan. 30, 2023.

BioMérieux Gets Health Canada Approval for Updated BioFire Blood Culture ID Panel

The panel includes additional pathogen targets and resistance genes, as well as revised targets compared to the original BCID panel.

BioMérieux Joint Infection Panel Gets FDA De Novo Authorization

The 39-target panel runs on FilmArray systems and tests for 31 pathogens implicated in most acute joint infections as well as eight antimicrobial resistance genes.

BioMérieux Reports 8 Percent Revenue Growth in Q4

The firm is expecting an overall sales decline in 2022 due to decreased demand for COVID-related products as the disease becomes endemic.

Co-Diagnostics to Seek FDA EUA for At-Home PCR Diagnostic System, COVID Test in Q1
Premium

Newly merged with a firm founded by BioFire Diagnostics alums, Co-Diagnostics plans to develop small panels for the system with up to six targets.

Jan 28, 2022

Streck Gets FDA Clearance for BioFire Sepsis Panel Control Material

Sep 1, 2021

BioMérieux H1 Revenues Rise 7 Percent

Aug 31, 2021

Startup BioFlyte Detects Airborne SARS-CoV-2 Using BioFire FilmArray
Premium

Jul 26, 2021

CDC to Withdraw EUA for COVID-19 Test; FDA Revokes Three Other EUAs for Non-Use, Agency Clearance

Mar 18, 2021

BioFire Dx Receives First FDA Marketing Clearance for SARS-CoV-2 Respiratory Panel

Jan 8, 2021

SARS-CoV-2 Mutations Present Unexpected Opportunities, Challenges for MDx Developers
Premium

Dec 8, 2020

BioMérieux Coronavirus Test Gets FDA OK for Use With Pooled Samples

Nov 6, 2020

Multiplex PCR Panels for Joint Infections on the Horizon
Premium

Oct 22, 2020

BioMérieux Q3 Revenues Increase 21 Percent

Oct 6, 2020

BioFire Diagnostics, UMass Medical Coronavirus Tests Get FDA Emergency Use Authorization

Aug 12, 2020

Traveler's Diarrhea Among Soldiers Linked to Gut Microbiome Changes

Jul 9, 2020

BioMérieux Reports 62 Percent BioFire FilmArray Sales Growth in Preliminary Q2 Release

May 19, 2020

BioMérieux's BioFire Pneumonia Panel Could Improve Care, Find Secondary Infection in COVID-19 Cases
Premium

May 4, 2020

BioMérieux's BioFire SARS-CoV-2 Respiratory Panel Wins FDA Emergency Use Authorization

Apr 16, 2020

BioMérieux Reports 22 Percent Q1 Revenue Growth, Withdraws Full-Year Guidance

Mar 24, 2020

BioMérieux Rapid Coronavirus Test Gets FDA Emergency Use Authorization

Mar 20, 2020

Commercial Coronavirus Test Developers Tweak Timelines, EUA Plans in Light of Loosened FDA Guidance

Mar 5, 2020

Coronavirus Dx Emergency Use Authorizations Progressing Rapidly Despite Criticism

Feb 26, 2020

BioMérieux Reports 11 Percent Revenue Growth in Q4

Feb 11, 2020

Qiagen Readying Updated Respiratory Panel for Emergency Coronavirus Testing

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.